Cite
HARVARD Citation
Ruiz-Morales, J. et al. (2016). First-line sunitinib versus pazopanib in metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium. European journal of cancer. pp. 102-108. [Online].